Shukra Pharmaceuticals Limited

BSE:524632 Stock Report

Market Cap: ₹4.5b

Shukra Pharmaceuticals Management

Management criteria checks 0/4

Shukra Pharmaceuticals' CEO is Dakshesh Shah, appointed in Aug 2015, has a tenure of 9.33 years. total yearly compensation is ₹5.04M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 1% of the company’s shares, worth ₹44.38M. The average tenure of the management team and the board of directors is 1.3 years and 1.3 years respectively.

Key information

Dakshesh Shah

Chief executive officer

₹5.0m

Total compensation

CEO salary percentage100.0%
CEO tenure9.3yrs
CEO ownership1.0%
Management average tenure1.3yrs
Board average tenure1.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Dakshesh Shah's remuneration changed compared to Shukra Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

₹144m

Jun 30 2024n/an/a

₹186m

Mar 31 2024₹5m₹5m

₹185m

Dec 31 2023n/an/a

₹185m

Sep 30 2023n/an/a

₹91m

Jun 30 2023n/an/a

₹45m

Mar 31 2023₹4mn/a

₹44m

Dec 31 2022n/an/a

₹11m

Sep 30 2022n/an/a

₹11m

Jun 30 2022n/an/a

₹10m

Mar 31 2022₹3mn/a

₹8m

Dec 31 2021n/an/a

₹77k

Sep 30 2021n/an/a

₹1m

Jun 30 2021n/an/a

₹522k

Mar 31 2021₹3m₹3m

₹2m

Compensation vs Market: Dakshesh's total compensation ($USD59.25K) is above average for companies of similar size in the Indian market ($USD42.37K).

Compensation vs Earnings: Dakshesh's compensation has increased by more than 20% in the past year.

CEO

Dakshesh Shah (52 yo)

9.3yrs

Tenure

₹5,040,000

Compensation

Mr. Dakshesh Rameshchandra Shah serves as a Director of Parshva Texchem (India) Private Limited and Parshva Alluminium Co. Private Limited. Being young entrepreneur and a successful businessman, Mr. Shah h...

Leadership Team

NamePositionTenureCompensationOwnership
Dakshesh Shah
Chairman & MD9.3yrs₹5.04m1.0%
₹ 44.4m
Arpita Kabra
Company Secretary & Compliance Officer3.9yrs₹66.00kno data
Payalben Mehta
Executive Directorno data₹138.00k0.52%
₹ 23.2m
Dhruvin Shah
Additional Executive Director1.3yrsno datano data
Sanskruti Patel
Additional Executive Director1.3yrsno datano data
Anar Patel
CFO & Whole Time Directorless than a yearno data1.0%
₹ 44.4m

1.3yrs

Average Tenure

37.5yo

Average Age

Experienced Management: 524632's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Dakshesh Shah
Chairman & MD12.6yrs₹5.04m1.0%
₹ 44.4m
Payalben Mehta
Executive Director12.6yrs₹138.00k0.52%
₹ 23.2m
Dhruvin Shah
Additional Executive Director1.3yrsno datano data
Sanskruti Patel
Additional Executive Director1.3yrsno datano data
Anar Patel
CFO & Whole Time Directorless than a yearno data1.0%
₹ 44.4m
Sarjeevan Rathore
Additional Independent Director1.3yrsno datano data
Bhoomiben Patel
Non-Executive Independent Director5.9yrsno datano data
Sonal Gandhi
Additional Non-Executive Independent Director1.3yrsno datano data
Jitendra Shah
Additional Independent Directorless than a yearno datano data
Pinki Sagar
Additional Non-Executive Independent Director1.1yrsno datano data

1.3yrs

Average Tenure

44yo

Average Age

Experienced Board: 524632's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:45
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shukra Pharmaceuticals Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution